Profile data is unavailable for this security.
About the company
Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company focused on the discovery and development of targeted solutions. The Company provides analytical services to evaluate the safety, efficacy, and performance of skincare and dermatological products. Skin + CELL is the Company’s luxury skincare brand, utilizing advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL’s range of products are based on clinically designed formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) that are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.
- Revenue in GBP (TTM)6.00k
- Net income in GBP-2.27m
- Incorporated2017
- Employees8.00
- LocationIncanthera PLC76 King StreetMANCHESTER M2 4NHUnited KingdomGBR
- Phone+44 161 817 5005
- Websitehttps://www.incanthera.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LN Future Invest AB | 1.68m | -161.77k | 810.47k | 6.00 | -- | 2.75 | -- | 0.4813 | -0.1776 | -0.1776 | 1.85 | 0.3231 | 2.18 | -- | 6.26 | -- | -20.92 | -36.79 | -43.13 | -61.66 | -- | -- | -9.61 | -20.44 | 1.06 | -- | 0.00 | -- | -11.69 | 1.31 | 59.18 | -- | -15.11 | -- |
| Lifeclean International AB (publ) | 4.49m | -2.93m | 1.18m | 22.00 | -- | 4.25 | -- | 0.2619 | -0.1967 | -0.1967 | 0.2391 | 0.0123 | 0.9943 | 2.50 | 10.28 | 2,483,318.00 | -64.90 | -57.58 | -147.54 | -103.98 | 46.41 | 44.86 | -65.28 | -75.31 | 0.4466 | -26.56 | 0.8905 | -- | -10.66 | 11.44 | 33.62 | -- | -58.15 | -- |
| Aqua Bio Technology ASA | -7.73bn | -7.73bn | 1.97m | 4.00 | -- | 2.79 | -- | -- | -- | -- | -- | 0.0563 | -- | -- | -- | -- | -- | -84.61 | -- | -182.60 | -- | 10.81 | -- | -306.70 | 0.0711 | -- | 0.9385 | -- | 478.93 | 160.31 | -1,504.61 | -- | 127.06 | -- |
| Photocat A/S | -8.22bn | -8.22bn | 2.16m | 10.00 | -- | 1.87 | -- | -- | -- | -- | -- | 2.35 | -- | -- | -- | -- | -- | -11.51 | -- | -14.26 | -- | 85.85 | -- | -17.08 | 0.7677 | -- | 0.1507 | -- | -24.65 | 10.97 | -31.32 | -- | 3.96 | -- |
| Incanthera PLC | 6.00k | -2.27m | 3.79m | 8.00 | -- | 5.02 | -- | 632.22 | -0.0187 | -0.0187 | 0.00005 | 0.0055 | 0.0029 | 0.0865 | 0.0186 | 750.00 | -110.62 | -142.49 | -170.49 | -223.28 | -1,416.67 | -- | -37,750.00 | -- | 0.8692 | -- | 0.00 | -- | -- | -- | -29.09 | -- | -- | -- |
| Miraculum SA | 10.38m | -421.80k | 7.44m | 49.00 | -- | 1.27 | -- | 0.7163 | -0.0429 | -0.0429 | 1.06 | 0.5952 | 0.8562 | 2.38 | 9.92 | 945,903.60 | -3.48 | -5.81 | -4.69 | -8.45 | 29.89 | 32.57 | -4.06 | -8.39 | 0.3003 | -0.5017 | 0.3359 | -- | 0.9695 | 16.91 | -120.02 | -- | -30.96 | -- |
| Harper Hygienics SA | 51.82m | 1.58m | 7.81m | 434.00 | 4.93 | 0.5323 | 2.63 | 0.1507 | 1.20 | 1.20 | 39.30 | 11.12 | 0.9843 | 5.00 | 3.51 | 576,482.80 | 3.01 | -- | 4.51 | -- | 30.56 | -- | 3.06 | -- | 0.8833 | 2.69 | 0.5842 | -- | -- | -- | -- | -- | -- | -- |
| Pharmena SA | 263.90k | -413.66k | 8.10m | 7.00 | -- | 3.71 | -- | 30.69 | -0.1793 | -0.1793 | 0.1144 | 0.9464 | 0.1063 | 0.3035 | 2.40 | 182,000.00 | -16.65 | -49.56 | -17.71 | -127.71 | 84.54 | 52.20 | -156.59 | -132.83 | 12.58 | -- | 0.0172 | -- | -78.58 | -52.51 | 92.91 | -- | -7.99 | -- |
| Clemondo Group AB (publ) | 23.32m | 521.47k | 10.02m | 61.00 | 19.21 | 1.04 | 5.88 | 0.4296 | 0.4582 | 0.4582 | 20.49 | 8.46 | 1.41 | 3.66 | 7.54 | 4,890,966.00 | 3.16 | 7.41 | 4.64 | 11.79 | 38.05 | 38.01 | 2.24 | 5.00 | 0.6396 | 8.08 | 0.307 | 0.00 | -6.04 | 1.20 | -38.04 | -- | 107.97 | -- |
| Delko SA | 158.24m | 389.42k | 16.40m | 1.04k | 42.11 | 0.5197 | 4.29 | 0.1036 | 0.1572 | 0.1572 | 63.88 | 12.74 | 2.26 | 0.1575 | 10.17 | 1,079,030.00 | 0.5558 | -- | 0.9472 | -- | 98.22 | -- | 0.2461 | -- | 0.6864 | 272.47 | 0.3846 | -- | -11.35 | -- | -80.99 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Odd Asset Management Ltd.as of 14 Aug 2024 | 23.54m | 17.06% |
| Unicorn Asset Management Ltd.as of 03 Jul 2025 | 13.07m | 9.47% |
| Premier Fund Managers Ltd.as of 31 Oct 2025 | 6.54m | 4.75% |
| Oberon Investments Ltd. (GB Investment Management)as of 30 Sep 2025 | 3.14m | 2.28% |
